348 related articles for article (PubMed ID: 16643358)
1. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
Zima E; Gergely M; Soós P; Gellér LA; Nemes A; Acsády G; Merkely B
J Cardiovasc Electrophysiol; 2006 Apr; 17(4):377-81. PubMed ID: 16643358
[TBL] [Abstract][Full Text] [Related]
2. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
[TBL] [Abstract][Full Text] [Related]
3. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
4. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
Hou CJ; Chang-Sing P; Flynn E; Martinez L; Peterson J; Ottoboni LK; Liem LB; Sung RJ
Circulation; 1995 Nov; 92(9):2558-64. PubMed ID: 7586357
[TBL] [Abstract][Full Text] [Related]
5. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
Sanghvi NK; Lelorier P; Gururaj AV; Monahan KM
Pacing Clin Electrophysiol; 2006 Sep; 29(9):926-9. PubMed ID: 16981914
[TBL] [Abstract][Full Text] [Related]
6. Comparison of defibrillation efficacy using implantable cardioverter-defibrillator with single- or dual-coil defibrillation leads and active can.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Raczak G; Swiatecka G
Kardiol Pol; 2005 Sep; 63(3):234-41; discussion 242-3. PubMed ID: 16180177
[TBL] [Abstract][Full Text] [Related]
7. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
Swerdlow CD; Ahern T; Kass RM; Davie S; Mandel WJ; Chen PS
J Am Coll Cardiol; 1996 Apr; 27(5):1112-8. PubMed ID: 8609329
[TBL] [Abstract][Full Text] [Related]
8. Effects of shock polarity reversal on defibrillation threshold in an implantable cardioverter-defibrillator.
Zienciuk A; Lubiński A; Królak T; Lewicka-Nowak E; Kempa M; Pazdyga A; Raczak G
Kardiol Pol; 2007 May; 65(5):495-500; discussion 501-2. PubMed ID: 17577846
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
Calvi V; Dugo D; Capodanno D; Arancio R; Di Grazia A; Liotta C; Puzzangara E; Ragusa A; Arestia A; Tamburino C
Am Heart J; 2010 Jan; 159(1):98-102. PubMed ID: 20102873
[TBL] [Abstract][Full Text] [Related]
10. [Safety and efficacy of intraoperative defibrillation threshold measured by defibrillation safety margin in 52 patients with implantable cardioverter defibrillator].
Zhang Y; Yuan KD; Tang BP; Ma YT; Zhang YY; Wang J; Li JX; Zhang JH; Xu GJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):975-8. PubMed ID: 21215224
[TBL] [Abstract][Full Text] [Related]
11. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol.
Lemke B; Lawo T; Zarse M; Lubinski A; Kreutzer U; Mueller J; Schuchert A; Mitzenheim S; Danilovic D; Deneke T;
Europace; 2008 Aug; 10(8):907-13. PubMed ID: 18515789
[TBL] [Abstract][Full Text] [Related]
12. Effects of sildenafil citrate on defibrillation efficacy.
Shinlapawittayatorn K; Sungnoon R; Chattipakorn S; Chattipakorn N
J Cardiovasc Electrophysiol; 2006 Mar; 17(3):292-5. PubMed ID: 16643403
[TBL] [Abstract][Full Text] [Related]
13. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
[TBL] [Abstract][Full Text] [Related]
14. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm.
Birgersdotter-Green U; Undesser K; Fujimura O; Feld GK; Kass RM; Mandel WJ; Peter CT; Chen PS
J Interv Card Electrophysiol; 1999 Jul; 3(2):155-61. PubMed ID: 10387143
[TBL] [Abstract][Full Text] [Related]
15. Defibrillation threshold testing: is it necessary during implantable cardioverter-defibrillator implantation?
Liu QM; Bai ZL; Liu ZJ; Li XP; Zhou SH
Med Hypotheses; 2009 Feb; 72(2):147-9. PubMed ID: 18980811
[TBL] [Abstract][Full Text] [Related]
16. Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants.
Keane D; Aweh N; Hynes B; Sheahan RG; Cripps T; Bashir Y; Zaidi A; Fahy G; Lowe M; Doherty P; Kroll MK
Pacing Clin Electrophysiol; 2007 May; 30(5):596-602. PubMed ID: 17461867
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy of pulsed biphasic waveform and rectilinear biphasic waveform in a short ventricular fibrillation pig model.
Li Y; Wang H; Cho JH; Didon JP; Bisera J; Weil MH; Tang W
Resuscitation; 2009 Sep; 80(9):1047-51. PubMed ID: 19604618
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
Lubiński A; Lewicka-Nowak E; Zienciuk A; Królak T; Kempa M; Pazdyga A; Swiatecka G
Kardiol Pol; 2005 Apr; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
[TBL] [Abstract][Full Text] [Related]
19. Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing.
Green UB; Garg A; Al-Kandari F; Ungab G; Tone L; Feld GK
J Interv Card Electrophysiol; 2003 Feb; 8(1):71-5. PubMed ID: 12652181
[TBL] [Abstract][Full Text] [Related]
20. A model of ischemically induced ventricular fibrillation for comparison of fixed-dose and escalating-dose defibrillation strategies.
Niemann JT; Rosborough JP; Walker RG
Acad Emerg Med; 2004 Jun; 11(6):619-24. PubMed ID: 15175198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
